Edge Therapeutics Prices ~7.315M Share IPO @$11.00/Share

Edge Therapeutics, Inc. EDGE today announced the pricing of its initial public offering of 7,315,151 shares of its common stock at a public offering price of $11.00 per share, before underwriting discounts and commissions.  All of the shares of common stock are being offered by Edge Therapeutics. In addition, Edge Therapeutics granted the underwriters a 30-day option to purchase up to an additional 1,097,272 shares of common stock at the same price, to cover over-allotments, if any. The shares are scheduled to begin trading on The NASDAQ Global Select Market on October 1, 2015 under the ticker symbol "EDGE."   Leerink Partners and Credit Suisse are acting as joint book-running managers for the offering.  Guggenheim Securities and JMP Securities are acting as co-managers.  The offering is being made only by means of a prospectus.  A copy of the final prospectus related to this offering will be filed with the Securities and Exchange Commission and may be obtained, when available, from Leerink Partners LLC, Attention: Syndicate Department, One Federal Street, 37th Floor, Boston, MA 02110, or by email at syndicate@leerink.com, See full press release